Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/153553
Title: Safety and effectiveness of switching to abacavir/lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)
Authors: Lim, Z. C.
Hoo, G. S.
Ang, J. H.
Teng, C. B.
Ang, L. W.
Lee, C. C.
Leo, Yee Sin
Law, Hwa Lin
Ng, Oon Tek
Wong, C. S.
Keywords: Science::Medicine
Issue Date: 2021
Source: Lim, Z. C., Hoo, G. S., Ang, J. H., Teng, C. B., Ang, L. W., Lee, C. C., Leo, Y. S., Law, H. L., Ng, O. T. & Wong, C. S. (2021). Safety and effectiveness of switching to abacavir/lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS). AIDS Research and Therapy, 18(1), 80-. https://dx.doi.org/10.1186/s12981-021-00402-7
Journal: AIDS Research and Therapy
Abstract: The efficacy and tolerability of an antiretroviral regimen are important considerations for selection of HIV-1 infection maintenance therapy. Abacavir/lamivudine plus rilpivirine (ABC/3TC + RPV) has been shown in international studies to be effective and well-tolerated in virologically suppressed individuals. This study evaluated the effectiveness and safety of switching to ABC/3TC + RPV as maintenance therapy in virologically suppressed HIV-1 infected individuals in Singapore.
URI: https://hdl.handle.net/10356/153553
ISSN: 1742-6405
DOI: 10.1186/s12981-021-00402-7
Rights: © The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativeco mmons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:LKCMedicine Journal Articles

Files in This Item:
File Description SizeFormat 
s12981-021-00402-7.pdf937.49 kBAdobe PDFView/Open

Page view(s)

36
Updated on May 19, 2022

Download(s)

16
Updated on May 19, 2022

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.